天美影院

Atellica NEPH 630 System

Smart, simple, and secure protein testing

Atellica庐 NEPH 630 System* combines proven nephelometric testing with the industry鈥檚 broadest menu of plasma protein samples.

  • More than 70 assay protocols accommodate multiple sample types.
  • Continuous random-access processing provides flexible sample management, easy calibration, and reliable results.
  • Wide initial measuring range reduces the need for retesting.
  • Intelligent and secure software offers password-protected, predefined user-access profiles and integrated sample result traceability.
Siemens Healthineers nephelometric analyzer Atellica NEPH 630 System

Benefits

Atellica NEPH 630 System features the industry鈥檚 largest nephelometric menu of plasma protein assays.

Atellica NEPH 630 System features the industry鈥檚 largest nephelometric menu of plasma protein assays.

  • Flexible testing options enable testing on serum, urine, plasma, and CSF.
  • Broad assay menu of more than 70 assays supports therapeutic drug monitoring, cardiac risk assessment, kidney diseases, neurological disorders, nutritional assessment, and iron and anemia assessment.
Intelligent software supports safe operation and timely data transmission, safeguards patient data, and facilitates quick, convenient technical support, if needed.

Intelligent software supports safe operation and timely data transmission, safeguards patient data, and facilitates quick, convenient technical support, if needed.

  • Predefined user-access profiles are password-protected to support tiered operator permission levels for safe system operation and patient data privacy.
  • Smart Remote Services identifies and diagnoses potential hardware issues, enabling rapid technical intervention and quicker resolution.
  • Advanced QC interface provides comprehensive statistics, allowing the transmission of control results to the LIS.
Continuous random access and a fast average throughput of 65 tests鈥 per hour support flexible sample processing and rapid results.

Continuous random access and a fast average throughput of 65 tests per hour support flexible sample processing and rapid results.

  • Flexible dilutions and automatic retesting can often be performed without re-accessing the primary sample.
  • Sophisticated sample dilutions enable you to quickly add tests or retest samples.
  • Samples and reagents can be loaded and reloaded continuously without interrupting the assay run.
  • Integrated sample result traceability functions support intuitive historical data search and provide access to 2 years of onboard data.
High-capacity storage and automated features reduce hands-on time.

High-capacity storage and automated features reduce hands-on time.

  • Onboard reagent and control storage provides 24/7 operation, long onboard stability, and minimized operator intervention.
  • High sample-loading capacity allows load-and-go processing.
  • Positive bar-code ID of primary sample tubes minimizes manual steps and avoids sample mismatch.
  • Automatic dilutions and repeat measurement of out-of-range high or low samples are performed without user intervention.
Proven nephelometric technology offers high precision and reproducibility that provide analytical advantages over turbidimetry in terms of precision and sensitivity.

Proven nephelometric technology offers high precision and reproducibility that provide analytical advantages over turbidimetry in terms of precision and sensitivity.1-4

  • High-sensitivity testing with nephelometry is considered the industry鈥檚 鈥済old standard鈥 and is recommended by the IMWG and ESMO guidelines.5-7
  • Wide initial measuring ranges and sophisticated antigen-excess pre-reaction protocols provide more-accurate results and fewer repeats.
  • System detects specimen and reagent levels prior to processing to ensure accuracy of results.
  • Graphical display of kinetic curves allows additional insight and advanced troubleshooting.
Innovative assays coupled with trusted and proven technologies support clinicians with reliable insight into disease determination and progression.

Innovative assays coupled with trusted and proven technologies support clinicians with reliable insight into disease determination and progression.

  • N Latex FLC assay is the first immunoassay with clearance for evaluation of monoclonal gammopathies of undetermined significance (MGUS).**,鈥犫赌
  • PROTIS庐 clinical decision support software consolidates patient test results into one simple report with algorithm-based interpretation of results to support physicians in clinical decision making.
  • Lot-to-lot consistency ensures concordance of results, providing physicians with reliable insight into the progression of disease.
  • More than 50 years of experience in protein analysis has led to longtime cooperation with IFCC in developing widely accepted standards.
Atellica NEPH 630 System features the industry鈥檚 largest nephelometric menu of plasma protein assays.

Atellica NEPH 630 System features the industry鈥檚 largest nephelometric menu of plasma protein assays.

  • Flexible testing options enable testing on serum, urine, plasma, and CSF.
  • Broad assay menu of more than 70 assays supports therapeutic drug monitoring, cardiac risk assessment, kidney diseases, neurological disorders, nutritional assessment, and iron and anemia assessment.

Assays

Polyclonal and Monoclonal Gammopathies/Immune System

10
脽2-尘颈肠谤辞驳濒辞产耻濒颈苍别
CLL kappa
CLL lambda
Ig/cha卯ne l茅g猫re, type kappa
Ig/cha卯ne l茅g猫re, type lambda
IgA
滨驳顿*,鈥♀赌
IgG
IgG sous-classes 1-4
IgM

Autoimmune/Rheumatoid Diseases

8
ADNase B
ASL
颁补濒辫谤辞迟别肠迟颈苍别*,鈥♀赌
C3c
C4
CRP
RF
Inhibiteurs du TNFa (adalimumab, infliximab, 茅tanercept)*

Complement Activity

6
Inhibiteur de la C1 est茅rase
颁1辩*,鈥♀赌
C3c
Proactivateur C3*,鈥♀赌
C4
颁5*,鈥♀赌

Coagulation Disorders

3
AT-III
贵颈产谤颈苍辞驳猫苍别
笔濒补蝉尘颈苍辞驳猫苍别

Kidney Disease

12
伪1-microglobuline urine
伪2-macroglobuline urine*
脽2-尘颈肠谤辞驳濒辞产耻濒颈苍别 urine
脽-trace prot茅ine*
Albuminurie
Cystatine C
CLL kappa urine*
CLL lambda urine*
Ig/cha卯ne l茅g猫re, type kappa urine*
Ig/cha卯ne l茅g猫re, type lambda urine*
IgG urine
Transferrine urine

Cardiovascular Risk/Acute Cardiac Care

9
Albuminurie
Apo A-I
Apo B
Cystatine C
贵颈产谤颈苍辞驳猫苍别
CRP haute sensibilit茅 (CardioPhase庐 hsCRP)
贬辞尘辞肠测蝉迟茅颈苍别
Lp(a)
Myoglobin

Chronic Alcohol Abuse

2
CDT (transferrine carboxy-d茅ficiente)
Transferrine (pour le calcul du %CDT)

Anemia/Iron Metabolism

5
Ferritine
Haptoglobine
贬茅尘辞辫别虫颈苍别
sTfR (r茅cepteur soluble de la transferrine)
Transferrine

Blood-CSF Barrier Dysfunction

11
Albumine
Albumine LCS
脽-trace prot茅ine (fuites de LCS)*
CLL kappa LCS*
CLL lambda LCS*
IgA
IgA LCS
IgG
IgG LCS
IgM
IgM LCS

Inflammation

4
伪1-glycoprot茅ine acide
CRP
贵颈产谤颈苍辞驳猫苍别
SAA*

Allergic Diseases

1
IgE

Other Specialty Analytes

6
伪1-补苍迟颈迟谤测辫蝉颈苍别
伪2-macroglobuline s茅rum
Apo A-II*
Apo E*
颁茅谤耻濒辞辫濒补蝉尘颈苍别
Fibronectine

Nutritional Assessment

5
Albumine
CRP
Ferritine
笔谤茅补濒产耻尘颈苍别
RBP (prot茅ine de liaison du r茅tinol)

Technical Details

 

  • Nephelometric measurement principle measures scattered light intensity at a fixed angle of 13鈥24掳.
  • More than 70 programmed assay protocols available.
  • Runs 65 tests/hour, depending on the assay mix.
  • Reaction cuvette capacity of 90 disposable cuvettes.
  • Flexible use of different sized sample tubes, including pediatric tubes.
  • Supports a variety of connectivity options, including Laboratory information systems (LIS), Smart Remote Services,搂 Atellica Data Manager, and Atellica Process Manager.
*
**
鈥犫赌
鈥♀赌
1
2
3
4
5
6
7